arrow
G

Giulia Maddalena

The University of Texas MD Anderson Cancer Center
H指数:10
被引数:379

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Circulating tumor DNA-guided de-escalation or escalation of adjuvant therapy in high-risk stage II and stage III colon cancer: the phase 2 PEGASUS trial

循环肿瘤DNA指导的高风险II期和III期结肠癌辅助治疗降级或升级:PEGASUS II期试验

2026-09-140
OAAI
Zanidatamab vs trastuzumab with or without PD-1 blockade in HER2-positive metastatic gastric cancer: a reconstructed patient-level pooled analysis

赞尼达他马 vs 曲妥珠单抗联合或不联合PD-1阻断剂在HER2阳性转移性胃癌中的比较:一项重建的患者水平合并分析

2026-07-140
OAAI
YAP-TAZ-TEAD transcriptional program is a prominent driver of acquired resistance to KRASG12C-based therapies in patients with metastatic colorectal cancer
2024-03-220
PRE
Transcriptomic Signatures of MSI-High Metastatic Colorectal Cancer Predict Efficacy of Immune Checkpoint Inhibitors
2023-07-135
OAAI
Extensive molecular profiling of squamous cell anal carcinoma in a phase 2 trial population: Translational analyses of the CARACAS study
2023-03-015
OAAI
The oncological multidimensional prognostic index is a promising decision-making tool: A real-world analysis in older patients with metastatic colorectal cancer
2022-12-015
PRE
Treatments after second progression in metastatic colorectal cancer: A pooled analysis of the TRIBE and TRIBE2 studies
2022-07-019
PRE
Synaptophysin expression in V600EBRAF-mutated advanced colorectal cancers identifies a new subgroup of tumours with worse prognosis

V600EBRAF-mutated晚期结直肠癌中突触素的表达确定了预后较差的新肿瘤亚组

2021-03-0110
PREAI